Dachaigh › Aillse nan dubhagan (Carcinoma cealla renach) › Tennessee › Nashville
Sgrùdaidhean clionaigeach Aillse nan dubhagan (Carcinoma cealla renach) ann an Nashville, TN
Tha 23 sgrùdaidhean airson Aillse nan dubhagan (Carcinoma cealla renach) a’ lorg phàirtichean aig làraichean ann agus timcheall air Nashville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
A’ fastadhÌre 1
- Research Site, Nashville
- Research Site, Nashville
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Tennessee Oncology, Nashville
A Phase 1 Study of the Safety and Tolerability of CTX-10726
A’ fastadhÌre 1
- SCRI Oncology Partners, Nashville
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
A’ fastadhÌre 1/2
- Vanderbilt University Medical Center ( Site 5004), Nashville
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
A’ fastadhÌre 1
- Sarah Cannon Research Institute (SCRI), Nashville
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #3, Nashville
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
A’ fastadhÌre 2
- Vanderbilt University/Ingram Cancer Center, Nashville
DESTINY-PANTUMOUR04
A’ fastadhSgrùdadh amharc
- Research Site, Nashville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
A’ fastadhSgrùdadh amharc
- Vanderbilt University Medical Center, Nashville
Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
A’ fastadhÌre 1
- Vanderbilt University Medical Center, Nashville
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
A’ fastadhÌre 1/2
- Vanderbilt University Medical Center, Nashville
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
A’ fastadhÌre 1/2
- Sarah Cannon Research Institute, Nashville
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A’ fastadhÌre 1/2
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC- Elliston Place Plaza, Nashville
- agus 11 a bharrachd
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
A’ fastadhÌre 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
A’ fastadhÌre 2
- Vanderbilt-Ingram Cancer Center, Nashville
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
A’ fastadhÌre 3
- Vanderbilt University/Ingram Cancer Center, Nashville
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
A’ fastadhÌre 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
A’ fastadhÌre 1
- Vanderbilt- Ingram Cancer Center, Nashville
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Vanderbilt University Medical Center, Nashville
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
A’ fastadhÌre 1
- SCRI Oncology Partners, Nashville
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
A’ fastadhÌre 1
- Xencor Investigative Site, Nashville
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
A’ fastadhÌre 1
- SCRI - Oncology Partners, Nashville
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
A’ fastadh
- Vanderbilt-Ingram Cancer Center, Nashville
Sgrùdaidhean Aillse nan dubhagan (Carcinoma cealla renach) ann am bailtean eile
- Houston, TX35 sgrùdaidhean
- New York City, NY27 sgrùdaidhean
- Dallas, TX23 sgrùdaidhean
- St. Louis, MO23 sgrùdaidhean
- Los Angeles, CA20 sgrùdaidhean
- Boston, MA16 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Philadelphia, PA15 sgrùdaidhean
- Pittsburgh, PA15 sgrùdaidhean
- Queens, NY15 sgrùdaidhean
- Rochester, MN14 sgrùdaidhean
- Cleveland, OH14 sgrùdaidhean
Sgrùdaidhean eile ann an Nashville
- Aillse Sgamhain Neo-chealla-beag97 sgrùdaidhean
- Aillse a' bhroilleach81 sgrùdaidhean
- Ailse metastatach70 sgrùdaidhean
- Aillse colorectal69 sgrùdaidhean
- Aillse (gach seòrsa)65 sgrùdaidhean
- Cancer Ovarian49 sgrùdaidhean
- Aillse Prostata43 sgrùdaidhean
- Ailseachadh nan Sgamhan40 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil39 sgrùdaidhean
- Cancer Pancreatic39 sgrùdaidhean
- Ailse Endometrial38 sgrùdaidhean
- Melanoma33 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.